Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P14
Within normal range
vs 3Y Ago
-3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2025-198.82%
2024-128.27%
202330.20%
202265.98%
2021-229.64%
2020-17.36%
2019-23.20%
201822.92%
201779.88%
2016-211.92%